Latest News
2020 has certainly been a year like no other and so was BCAC’s 15th Annual General Meeting – our first to be conducted online as a virtual event. Clearly everyone’s ‘Zooming’ skills have become well-honed and we had a great turnout.
Media Release 28 October 2020
Research has shown that certain lifestyle factors and health behaviours can have a positive impact upon quality of life, chronic disease risk factors and other health related areas, for women after cancer.
A team of leading Australian and New Zealand health researchers is undertaking a study to pilot a positive lifestyle intervention in New Zealand women. This aims to improve health and wellness in younger women after treatment for cancer.
Most of us are familiar with Herceptin – the medicine that transformed the treatment of HER2-positive breast cancer in the early 2000s. Herceptin is the brand name for this drug which is supplied by pharmaceutical company Roche. Trastuzumab is its generic name.
The Advanced Breast Cancer Global Alliance, of which BCAC is a member, has joined with other international cancer groups to call for a global plan of action for cancer to meet the challenges of COVID-19 and future pandemics or health crises...
Breast surgeon Dr Eva Juhasz has recently finished a study of the current treatment of elderly breast cancer patients in Waitematā DHB.
A new research project here in New Zealand aims to explore how women with mastectomies and breast reconstructive surgery experience their bodies, particularly focusing on the roles that bras, breasts and body image play in their lives after surgery.
BCAC has joined an international effort to improve and extend the lives of women and men living with advanced breast cancer (ABC). The ABC Global Alliance was formed in 2016 by the European School of Oncology and is a non-profit organisation based in Portugal.
A clinical trial that could significantly improve quality of life for women with moderate arm lymphoedema is underway in Hamilton.
